Jesús Porta-Etessam
Has grant
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
promoción e impulso de la investigación biomédica
Open Date: 2016-10-01
Close Date: 2017-10-01
Articles (20)
Year:
2026
Year:
2026
Year:
2026
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Introduction Effectiveness of candesartan in migraine prevention is supported by two randomized controlled trials. We aimed to assess the effectiveness, tolerability, and response predictors of candesartan in the preventive treatment of migraine. Methods Observational, multicenter, prospective cohort study. The 50%, 75% and 30% responder rates, between weeks 8–12 and 20–24, were compared with the baseline. Treatment emergent adverse effects were systematically evaluated. Response predictors were estimated by multivariate regression models. Results Eighty-six patients were included, 79.1% females, aged 39.5 (inter-quartile range [IQR] 26.3–50.3), with chronic migraine (43.0%), medication overuse headache (55.8%) and a median of two (inter-quartile range: 0.75–3) prior preventive treatments. At baseline patients had 14 (10–24) headache and 8 (5–11) migraine days per month. The 30%, 50% and 75% responder rates were 40%, 34.9% and 15.1% between weeks 8–12, and 48.8%, 36%, and 18.6% between weeks 20–24. Adverse effects were reported by 30 (34.9%) and 13 (15.1%) patients between weeks 0–12 and 12–24, leading to discontinuation in 15 (17.4%) patients. Chronic migraine, depression, headache days per month, medication overuse headache, and daily headache at baseline predicted the response between weeks 20–24. Conclusion Candesartan effectiveness and tolerability in migraine prevention was in line with the clinical trials’ efficacy. Trial registration: The study protocol is registered in ClinicalTrials.gov (NCT04138316).
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (11)
Alex Jaimes
Universidad Autónoma de Madrid
María-Luz Cuadrado
Universidad Complutense de Madrid
Andrés Soto-Varela
Jefe de Servicio y Profesor Titular
Servicio Andaluz de Salud
Lidiane Lima Florencio
Profesor
Universidad Rey Juan Carlos
Marcos Polanco Fernández
Marqués de Valdecilla University Hospital
Albert Muñoz-Vendrell
Multiple Sclerosis Unit | Headache Unit
Bellvitge University Hospital
Francisco Javier Domingo Espineira
Associate Professor (Lecturer)
Universidad a Distancia de Madrid (UDIMA)
Óscar Fraile Martínez
Universidad de Alcalá
Margarita Sanchez Del Rio
Headache specialist
Clinica Universidad de Navarra
SANTOS LASAOSA
professor
Universidad de Zaragoza
Angel Luis Guerrero-Peral
Universidad de Valladolid
Make your next move.
Prepare your application
Review drafts before you send them.